DYN · Dyne Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Dirk Kersten | ▼ Sell | Open Market | 3,586,796 Shares held | 7/27/2026 | View profile |
| Atlas Venture Opportunity Fund II, L.P. 10% Owner | ▲ Buy | Open Market | 934,581 Shares held | 12/12/2022 | View profile |
| Atlas Venture Fund XI, L.P. 10% Owner | ▼ Sell | Open Market | 864,487 Shares held | 2/28/2024 | View profile |
| Atlas Venture Opportunity Fund I, L.P. | ▼ Sell | Open Market | 847,388 Shares held | 3/1/2024 | View profile |
| Joshua T. Brumm Chief Executive Officer | ▼ Sell | Open Market | 537,998 Shares held | 3/11/2024 | View profile |
| Jason P. Rhodes Director | ▼ Sell | Open Market | 428,946 Shares held | 8/14/2026 | View profile |
| John Cox CEO & President | ▼ Sell | Open Market | 357,507 Shares held | 9/8/2026 | View profile |
| Beskrovnaya Oxana Chief Scientific Officer | ▼ Sell | Open Market | 195,840 Shares held | 3/11/2025 | View profile |
| Douglas Kerr Chief Medical Officer | ▼ Sell | Open Market | 162,564 Shares held | 9/8/2026 | View profile |
| Johanna Friedl-Naderer Chief Commercial Officer | ▼ Sell | Open Market | 152,897 Shares held | 9/8/2026 | View profile |
| Farwell Wildon Chief Medical Officer | ▼ Sell | Open Market | 143,222 Shares held | 8/19/2024 | View profile |
| Jonathan McNeill President and COO | ▼ Sell | Open Market | 132,106 Shares held | 8/19/2024 | View profile |
| HIGH SUSANNA GATTI Chief Operating Officer | ▼ Sell | Open Market | 131,636 Shares held | 9/18/2024 | View profile |
| Richard William Scalzo Chief Financial Officer | ▼ Sell | Open Market | 122,330 Shares held | 3/11/2025 | View profile |
| Erick Lucera Chief Financial Officer | ▼ Sell | Open Market | 119,766 Shares held | 8/13/2026 | View profile |
| Brian S. Posner Director | ▲ Buy | Open Market | 27,000 Shares held | 10/2/2026 | View profile |
| David Charles Lubner | ▼ Sell | Gift | 0 Shares held | 4/24/2026 | View profile |
| Incerti Carlo | ▼ Sell | Open Market | 0 Shares held | 11/18/2024 | View profile |
Transaction History
| Brian S. Posner | ▲ Buy | Open Market | 2,500 | $40K | 10/2/2026 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 185 | $3K | 9/8/2026 |
| Douglas Kerr | ▼ Sell | Open Market | 1,290 | $24K | 9/8/2026 |
| John Cox | ▼ Sell | Open Market | 5,658 | $107K | 9/8/2026 |
| Douglas Kerr | ▼ Sell | Open Market | 3,745 | $91K | 9/4/2026 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 900 | $22K | 9/4/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 478,377 | $12.0M | 8/14/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 322,465 | $8.1M | 8/14/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 1,359,674 | $34.0M | 8/14/2026 |
| Erick Lucera | ▼ Sell | Open Market | 1,797 | $47K | 8/13/2026 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 226 | $6K | 8/13/2026 |
| Douglas Kerr | ▼ Sell | Open Market | 1,556 | $41K | 8/13/2026 |
| John Cox | ▼ Sell | Open Market | 4,986 | $131K | 8/13/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 268,354 | $7.0M | 8/13/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 94,415 | $2.5M | 8/13/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 63,643 | $1.7M | 8/13/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 256,072 | $6.5M | 7/27/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 5,388 | $140K | 7/27/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 11,665 | $276K | 7/7/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 5,000 | $118K | 7/7/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 124,379 | $2.9M | 7/7/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 29,587 | $699K | 7/7/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 62,543 | $1.4M | 7/7/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 14,844 | $351K | 7/7/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 49,193 | $1.1M | 7/7/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 253,039 | $5.8M | 7/6/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 127,182 | $2.9M | 7/6/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 100,019 | $2.3M | 7/6/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 102,969 | $2.2M | 6/29/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 40,702 | $860K | 6/29/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 51,756 | $1.1M | 6/29/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 162,954 | $3.5M | 6/26/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 81,903 | $1.7M | 6/26/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 64,411 | $1.4M | 6/26/2026 |
| Erick Lucera | ▼ Sell | Open Market | 2,362 | $48K | 6/25/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 12,699 | $268K | 6/25/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 6,382 | $135K | 6/25/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 5,019 | $106K | 6/25/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 50,530 | $1.1M | 6/24/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 25,397 | $534K | 6/24/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 19,973 | $420K | 6/24/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 77,855 | $1.6M | 6/23/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 39,131 | $827K | 6/23/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 30,774 | $650K | 6/23/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 71,629 | $1.5M | 6/23/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 1,657 | $36K | 6/23/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 190,676 | $3.9M | 6/22/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 46,901 | $941K | 6/18/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 37,454 | $754K | 6/17/2026 |
| John Cox | ▼ Sell | Open Market | 2,683 | $49K | 6/16/2026 |
| Douglas Kerr | ▼ Sell | Open Market | 887 | $16K | 6/16/2026 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 145 | $3K | 6/16/2026 |
| Brian S. Posner | ▲ Buy | Open Market | 2,000 | $34K | 6/8/2026 |
| Brian S. Posner | ▲ Buy | Open Market | 2,500 | $44K | 6/3/2026 |
| Brian S. Posner | ▲ Buy | Open Market | 2,000 | $36K | 5/26/2026 |
| Brian S. Posner | ▲ Buy | Open Market | 2,500 | $43K | 5/20/2026 |
| Erick Lucera | ▼ Sell | Open Market | 1,448 | $27K | 5/13/2026 |
| John Cox | ▼ Sell | Open Market | 3,311 | $61K | 5/13/2026 |
| Douglas Kerr | ▼ Sell | Open Market | 1,564 | $29K | 5/13/2026 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 228 | $4K | 5/13/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 17,244 | $313K | 5/6/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 21,926 | $399K | 5/6/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 43,621 | $793K | 5/6/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 428 | $8K | 5/6/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 6,081 | $110K | 5/5/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 60 | $1K | 5/5/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 2,403 | $43K | 5/5/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 3,056 | $55K | 5/5/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 3,136 | $56K | 5/4/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 6,241 | $112K | 5/4/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 61 | $1K | 5/4/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 2,466 | $44K | 5/4/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 59,870 | $1.1M | 4/28/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 119,115 | $2.2M | 4/28/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 1,170 | $22K | 4/28/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 47,082 | $865K | 4/28/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 26 | $494 | 4/28/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 1 | $19 | 4/28/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 21 | $399 | 4/28/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 52 | $988 | 4/28/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 45,709 | $830K | 4/27/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 90,943 | $1.7M | 4/27/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 894 | $16K | 4/27/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 35,947 | $652K | 4/27/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 36,345 | $672K | 4/24/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 72,310 | $1.3M | 4/24/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 710 | $13K | 4/24/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 28,583 | $528K | 4/24/2026 |
| David Charles Lubner | ▼ Sell | Gift | 53,625 | $0 | 4/24/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 38,322 | $735K | 4/23/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 377 | $7K | 4/23/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 15,148 | $291K | 4/23/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 19,261 | $370K | 4/23/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 150,942 | $3.0M | 4/22/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 1,485 | $29K | 4/22/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 59,663 | $1.2M | 4/22/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 2,652 | $53K | 4/22/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 75,866 | $1.5M | 4/22/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 71,499 | $1.4M | 4/21/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 142,253 | $2.8M | 4/21/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 56,228 | $1.1M | 4/21/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 15 | $301 | 4/21/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 605 | $12K | 4/21/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 769 | $15K | 4/21/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 1,530 | $31K | 4/21/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 8,300 | $166K | 4/21/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 1,398 | $27K | 4/21/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 142,604 | $2.9M | 4/20/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 1,401 | $28K | 4/20/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 56,368 | $1.1M | 4/20/2026 |
| Jason P. Rhodes | ▼ Sell | Open Market | 71,676 | $1.4M | 4/20/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 125,274 | $2.5M | 4/20/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 211,974 | $4.3M | 4/17/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 11,116 | $235K | 4/16/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 6,657 | $134K | 4/16/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 81,840 | $1.7M | 4/15/2026 |
| Erick Lucera | ▼ Sell | Open Market | 5,727 | $107K | 4/1/2026 |
| Brian S. Posner | ▲ Buy | Open Market | 2,000 | $34K | 3/30/2026 |
| Brian S. Posner | ▲ Buy | Open Market | 2,000 | $39K | 3/11/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 129,672 | $2.5M | 3/11/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 219,758 | $4.2M | 3/10/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 281,858 | $5.6M | 3/10/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 9,482 | $173K | 3/10/2026 |
| Dirk Kersten | ▼ Sell | Open Market | 177,690 | $3.1M | 3/9/2026 |
| Brian S. Posner | ▲ Buy | Open Market | 3,000 | $45K | 3/6/2026 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 148 | $2K | 3/5/2026 |
| John Cox | ▼ Sell | Open Market | 2,732 | $41K | 3/5/2026 |
| Douglas Kerr | ▼ Sell | Open Market | 904 | $13K | 3/5/2026 |
| John Cox | ▲ Buy | Grant | 180,000 | $0 | 2/12/2026 |
| Douglas Kerr | ▲ Buy | Grant | 85,000 | $0 | 2/12/2026 |
| Erick Lucera | ▲ Buy | Grant | 65,000 | $0 | 2/12/2026 |
| Johanna Friedl-Naderer | ▲ Buy | Grant | 60,000 | $0 | 2/12/2026 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 144 | $3K | 12/5/2025 |
| John Cox | ▼ Sell | Open Market | 2,662 | $55K | 12/5/2025 |
| Douglas Kerr | ▼ Sell | Open Market | 880 | $18K | 12/5/2025 |
| John Cox | ▼ Sell | Open Market | 2,640 | $35K | 9/5/2025 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 144 | $2K | 9/5/2025 |
| Douglas Kerr | ▼ Sell | Open Market | 873 | $12K | 9/5/2025 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 894 | $12K | 9/4/2025 |
| Douglas Kerr | ▼ Sell | Open Market | 3,552 | $47K | 9/4/2025 |
| John Cox | ▼ Sell | Gift | 10,000 | $0 | 7/15/2025 |
| John Cox | ▼ Sell | Gift | 10,000 | $0 | 7/15/2025 |
| John Cox | ▼ Sell | Gift | 10,000 | $0 | 7/15/2025 |
| John Cox | ▼ Sell | Gift | 10,000 | $0 | 7/15/2025 |
| John Cox | ▲ Buy | Open Market | 100,000 | $911K | 7/14/2025 |
| John Cox | ▼ Sell | Open Market | 4,060 | $54K | 6/5/2025 |
| Douglas Kerr | ▼ Sell | Open Market | 1,342 | $18K | 6/5/2025 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 146 | $2K | 6/5/2025 |
| Erick Lucera | ▲ Buy | Grant | 66,100 | $0 | 3/31/2025 |
| Johanna Friedl-Naderer | ▼ Sell | Open Market | 143 | $2K | 3/13/2025 |
| Richard William Scalzo | ▼ Sell | Open Market | 1,343 | $15K | 3/11/2025 |
| Beskrovnaya Oxana | ▼ Sell | Open Market | 2,153 | $25K | 3/11/2025 |
| Douglas Kerr | ▼ Sell | Open Market | 1,343 | $16K | 3/5/2025 |
| Richard William Scalzo | ▼ Sell | Open Market | 917 | $11K | 3/5/2025 |
| Beskrovnaya Oxana | ▼ Sell | Open Market | 1,094 | $13K | 3/5/2025 |
| John Cox | ▼ Sell | Open Market | 4,061 | $48K | 3/5/2025 |
| Beskrovnaya Oxana | ▼ Sell | Open Market | 2,598 | $36K | 2/18/2025 |
| Richard William Scalzo | ▼ Sell | Open Market | 2,488 | $35K | 2/18/2025 |
| Jason P. Rhodes | ▲ Buy | Grant | 1,111,111 | $15.0M | 1/27/2025 |
| Richard William Scalzo | ▼ Sell | Open Market | 1,455 | $41K | 12/11/2024 |
| Beskrovnaya Oxana | ▼ Sell | Open Market | 2,334 | $66K | 12/11/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 34,437 | $1.0M | 12/9/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 101,675 | $3.0M | 12/6/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 3,806 | $111K | 12/5/2024 |
| Johanna Friedl-Naderer | ▲ Buy | Grant | 37,800 | $0 | 12/4/2024 |
| Richard William Scalzo | ▲ Buy | Grant | 32,700 | $0 | 12/4/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 135,039 | $4.0M | 12/4/2024 |
| Douglas Kerr | ▲ Buy | Grant | 48,000 | $0 | 12/4/2024 |
| John Cox | ▲ Buy | Grant | 145,300 | $0 | 12/4/2024 |
| Beskrovnaya Oxana | ▲ Buy | Grant | 39,100 | $0 | 12/4/2024 |
| Beskrovnaya Oxana | ▲ Buy | Grant | 27,400 | $0 | 12/4/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 29,732 | $864K | 12/3/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 79,973 | $2.4M | 12/2/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 1,228 | $37K | 12/2/2024 |
| Incerti Carlo | ▲ Buy | Option Exercise | 16,500 | $143K | 11/18/2024 |
| Incerti Carlo | ▼ Sell | Open Market | 16,500 | $474K | 11/18/2024 |
| Beskrovnaya Oxana | ▼ Sell | Open Market | 2,856 | $81K | 11/18/2024 |
| Richard William Scalzo | ▼ Sell | Open Market | 2,735 | $77K | 11/18/2024 |
| Jason P. Rhodes | ▼ Sell | Open Market | 583 | $19K | 11/14/2024 |
| Jason P. Rhodes | ▼ Sell | Open Market | 4 | $132 | 11/14/2024 |
| Jason P. Rhodes | ▼ Sell | Open Market | 123 | $4K | 11/14/2024 |
| Jason P. Rhodes | ▼ Sell | Open Market | 72 | $2K | 11/14/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 8,929 | $293K | 11/14/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 10,803 | $381K | 11/13/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 121 | $4K | 10/21/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 13,414 | $472K | 10/18/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 13,013 | $458K | 10/17/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 23,671 | $837K | 10/16/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 5,441 | $191K | 10/3/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 21,518 | $761K | 10/2/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 8,423 | $296K | 10/1/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 1,935 | $70K | 9/30/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 29,007 | $1.0M | 9/30/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 32 | $1K | 9/27/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 1,260 | $44K | 9/26/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 2,357 | $83K | 9/25/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 36,221 | $1.3M | 9/23/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 4,610 | $167K | 9/23/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 78,940 | $2.9M | 9/20/2024 |
| Dirk Kersten | ▼ Sell | Open Market | 471 | $17K | 9/20/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Dyne Therapeutics highlighted in recent healthcare stock coverage
Dyne Therapeutics appeared in a Benzinga pre‑market roundup of 12 health‑care stocks. Yahoo highlighted the company in a piece about why it is back in the spotlight, and Raymond James analysts listed it among four health‑care stocks they back. The coverage brings renewed attention to DYN as it trades near its recent support level.
Dyne Therapeutics highlighted in recent healthcare stock coverage. Dyne Therapeutics appeared in a Benzinga pre‑market roundup of 12 health‑care stocks. Yahoo highlighted the company in a piece about why it is back in the spotlight, and Raymond James analysts listed it among four health‑care stocks they back. The coverage brings renewed attention to DYN as it trades near its recent support level.